Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Washable, Wireless Mouse Prevents Cross-Contamination

July 28, 2010 6:23 am | Product Releases | Comments

Econo-Keys, a leading manufacturer of medical keyboards and mice, recently introduced the EKW-M, a completely waterproof, wireless mouse designed for the healthcare community.

Dyax numbers get boost from fees, drug sales

July 28, 2010 5:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge-based biotech firm Dyax Corp. saw a surge in revenue for the second quarter, climbing to $15.1 million from $4.8 million for the same quarter in 2009. The bulk of that increase, $13.2 million, came from development and license fees.

Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa. , July 28 /- Topaz Pharmaceuticals Inc., a privately held biotechnology company, announced positive results of studies of topical ivermectin cream, which it is developing as a potential  treatment of Pediculus humanus capitis (head lice).   In a Phase 2 dose-ranging...

TOPICS:
Advertisement

Texas Health Plano, Texas Back Institute Offer SpineAssist Surgical Robot for Spine Surgeries

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

Internationally renowned Plano surgeon co-invented technology PLANO, Texas , July 28 /PRNewswire-USNewswire/ -- Fifteen-year-old Tressa Scott of Allen hasn't been able to stand up straight for more than a year - until now. The Allen teenager grew an inch and a half and gained a...

TOPICS:

Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2010

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif. , July 28 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced that it will report results for its fourth quarter and fiscal year 2010, ended June 30, 2010 on Tuesday, August 31, 2010 after the market closes. A conference...

TOPICS:

Baylor College of Medicine awarded $14.85 million grant to complete neurological research center at Texas Children's Hospital

July 28, 2010 5:38 am | by Baylor College of Medicine | News | Comments

Neurological research at Baylor College of Medicine and Texas Children's Hospital is getting a big boost in the form of a $14.85 million grant from the National Institutes of Health to complete two floors of the Jan and Dan Duncan Neurological Research Institute at Texas Children's...

TOPICS:

GTC Biotherapeutics flirts with profits in Q2

July 28, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Framingham drug developer GTC Biotherapeutics Inc. cut its losses for the second quarter of the year to $300,000 against a loss of $10.8 million for the second quarter of 2009.

TOPICS:

Qualcomm Monitoring Health of Japanese Seniors

July 28, 2010 5:37 am | by San Diego Business Journal | News | Comments

In partnership with a Japanese corporation, Qualcomm Inc. said July 22 that it has embarked on an experiment to monitor the health of 300 elderly residents in rural Japan, including areas of snow-prone Hokkaido in the north.

TOPICS:
Advertisement

Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH)

July 28, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 28 /- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the signing of a cooperative research and development agreement (CRADA) with the National Institute...

TOPICS:

EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS

July 28, 2010 2:35 am | by Bio-Medicine.Org | News | Comments

ROCKLAND, Mass. , July 28 /- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany , announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple...

TOPICS:

Morphine blocks tumor growth

July 27, 2010 10:32 pm | by EurekAlert | News | Comments

(American Journal of Pathology) Current research suggests that taking morphine can block new blood vessel and tumor growth. The related report by Koodie et al, "Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway," appears in the August 2010 issue of the American...

TOPICS:

Speeding Up Diagnosis of Infectious Disease

July 27, 2010 8:35 pm | by Massachusetts Institute of Technology | News | Comments

A startup is developing sequencing-based tests that could detect infections within 24 hours.

TOPICS:

NuVasive 2Q net income jumps on sales boost

July 27, 2010 2:45 pm | by The Associated Press | News | Comments

NuVasive Inc. said Tuesday that its second-quarter net income surged on a boost in sales of surgical systems. The medical device maker also raised its earnings guidance for the year.The company said it earned $6.7 million, or 17 cents per share, up from $2.8 million, or 7 cents per share,...

Reform of primary care could reduce diagnostic errors

July 27, 2010 12:33 pm | by Baylor College of Medicine | News | Comments

Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant,...

TOPICS:

Fluxion Biosciences wins R & D 100 award for the IonFlux HT System

July 27, 2010 11:35 am | by I-Micronews | News | Comments

Fluxion Biosciences, a leading provider of functional cell analysis systems for drug discovery and diagnostics, announced that it has won a 2010 R&D 100 Award for its IonFlux? HT System.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading